Drug therapy for solitary cysticercus granuloma
A systematic review and meta-analysis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 16, 2012
- Accepted August 23, 2012
- First Published December 26, 2012.
Article Versions
- Previous version (December 26, 2012 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Willem M. Otte, PhD,
- Monika Singla, MD, PhD,
- Josemir W. Sander, PhD, FRCP and
- Gagandeep Singh, MD, PhD
- Willem M. Otte, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Monika Singla, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Josemir W. Sander, PhD, FRCP and
1) GSK Pharma - membership of Advisory Board2) Viropharma - membership of Advisory Board3) UCB Pharma - membership of Advisory Board
NONE
1) UCB Pharma - travel grant2) Janssen Cilag - travel grant
1) Lancet Neurology - member of Editorial Board2) Epilepsia - member of Editorial Board3) Epileptic Disorders - member of Editorial Board
NONE
NONE
NONE
NONE
1) UCB Pharma - membership of Speakers' Bureau2) GSK Pharma - Membership of Speakers' Bureau
NONE
NONE
1) UCB Pharma - research grant to my department2) GSK - research grant to my department
1) NIH Grant number 1R21NS069223-01. PI, 2010 - 20122) CBRC Project Grant ID: 6BFP/06. PI, 2008-20123) European Union Seventh Framework Programme.Large-scale-collaborative project 20138. Associate PI,2008 - 2011
1) Wellcome Trust. Grant number: 084730. PI 2008 - 2011
1) Nationaal Epilepsie Fonds Nederland Projectnumber:10-07. PI, 2010 - 20132) The Brain Research Trust Project Grant 01-81/09. PI,2009 - 2010
NONE
NONE
NONE
NONE
NONE
NONE
- Gagandeep Singh, MD, PhD
NONE
NONE
NONE
Associate Editor Neurology IndiaMember Editorial Board Epilepsia
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Indian Council of Medical Research
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Pediatric Neurology (W.M.O.), Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands; Biomedical MR Imaging and Spectroscopy Group (W.M.O.), Image Sciences Institute, University Medical Center Utrecht, The Netherlands; Department of Neurology (M.S., G.S.), Dayanand Medical College, Ludhiana, Punjab, India; UCL Institute of Neurology (J.W.S.), Queen Square, London, UK; and SEIN (J.W.S.), Epilepsy Institutes in the Netherlands Foundation, Heemstede, The Netherlands.
- Correspondence to W.M. Otte: wim{at}invivonmr.uu.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Views and Reviews
A diagnostic and therapeutic scheme for a solitary cysticercus granulomaG. Singh, V. Rajshekhar, J.M.K. Murthy et al.Neurology, December 13, 2010 -
Five New Things
NeurocysticercosisFive new thingsArturo Carpio, Agnès Fleury, W. Allen Hauser et al.Neurology: Clinical Practice, April 15, 2013 -
Views & Reviews
Treatment of neurocysticercosisCurrent status and future research needsT. E. Nash, G. Singh, A. C. White et al.Neurology, October 09, 2006 -
Brief Communications
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosisF. Göngora-Rivera, J. L. Soto-Hernández, D. González Esquivel et al.Neurology, December 28, 2005